What exactly is a mood stabilizer?
作者信息
Young L Trevor
出版信息
J Psychiatry Neurosci. 2004 Mar;29(2):87-8.
Abstract
摘要
相似文献
1
What exactly is a mood stabilizer?究竟什么是情绪稳定剂？
J Psychiatry Neurosci. 2004 Mar;29(2):87-8.
2
Increasing sophistication of the pharmacotherapy of mood disorders.情绪障碍药物治疗的日益精细化。
J Psychiatry Neurosci. 2002 Mar;27(2):89.
3
[Mechanism and clinical effects of drugs for mood disorder].
Ryoikibetsu Shokogun Shirizu. 2003(38):358-61.
4
Mood stabilizers for patients with bipolar disorder: the state of the art.心境稳定剂治疗双相障碍患者：现状。
Expert Rev Neurother. 2011 Jan;11(1):85-99. doi: 10.1586/ern.10.181.
5
Algorithms for the treatment of affective illness, primary disorder of vigilance, and task-dependent attention disorders (learning disabilities) in children and adolescents.儿童和青少年情感障碍、原发性警觉障碍以及任务依赖性注意力障碍（学习障碍）的治疗算法。
J Child Neurol. 1996 May;11(3):220-7. doi: 10.1177/088307389601100312.
6
Adolescent psychopharmacology: drugs for mood disorders.青少年精神药理学：用于情绪障碍的药物
Adolesc Med Clin. 2006 Oct;17(3):789-808; abstract xiii-xiv. doi: 10.1016/j.admecli.2006.06.003.
7
Lithium in neuropsychiatry: a 2010 update.神经精神医学中的锂：2010 年更新。
World J Biol Psychiatry. 2011 Aug;12(5):340-8. doi: 10.3109/15622975.2011.559274. Epub 2011 Mar 2.
8
Mood disorders and dental implications.情绪障碍与牙齿问题
J Mass Dent Soc. 2003 Fall;52(3):38-42.
9
[Mood disorders. Bipolar psychosis].
Rev Prat. 2004 Apr 30;54(8):877-83; quiz 884.
10
Atypical mood stabilizers: a new role for neuroleptics?非典型心境稳定剂：抗精神病药物的新作用？
Bipolar Disord. 2011 Nov-Dec;13(7-8):583-6. doi: 10.1111/j.1399-5618.2011.00967.x.
引用本文的文献
1
Central nervous system-related safety and tolerability of add-on ketamine to antidepressant medication in treatment-resistant depression: focus on the unique safety profile of bipolar depression.难治性抑郁症中，抗抑郁药物联用氯胺酮治疗时与中枢神经系统相关的安全性及耐受性：聚焦双相抑郁症独特的安全性特征
Ther Adv Psychopharmacol. 2021 May 19;11:20451253211011021. doi: 10.1177/20451253211011021. eCollection 2021.
2
Metabolic Risk Factors and Cardiovascular Safety in Ketamine Use for Treatment Resistant Depression.氯胺酮用于治疗抵抗性抑郁症时的代谢风险因素与心血管安全性
Neuropsychiatr Dis Treat. 2020 Oct 29;16:2539-2551. doi: 10.2147/NDT.S273287. eCollection 2020.
3
Risk Variant and Mood Stabilizers Effects in the Prefrontal Cortical Thickness of Mexican Patients with Bipolar Disorder.墨西哥双相情感障碍患者前额叶皮质厚度的风险变异体与心境稳定剂效应
Neuropsychiatr Dis Treat. 2020 May 12;16:1199-1206. doi: 10.2147/NDT.S245911. eCollection 2020.
4
Factors associated with high-dose antipsychotic prescriptions in outpatients with schizophrenia: An analysis of claims data from a Japanese prefecture.与精神分裂症门诊患者高剂量抗精神病药物处方相关的因素：来自日本一个县的理赔数据分析。
Neuropsychopharmacol Rep. 2020 Sep;40(3):224-231. doi: 10.1002/npr2.12109. Epub 2020 May 26.
5
The diagnostic dilemma: why we need to change how we diagnose bipolar disorder in children.诊断困境：为何我们需要改变儿童双相情感障碍的诊断方式。
Cerebrum. 2010 Nov;2010:23. Epub 2010 Nov 10.
6
Fronto-limbic dysfunction in mania pre-treatment and persistent amygdala over-activity post-treatment in pediatric bipolar disorder.成人双相障碍治疗前额-边缘系统功能障碍和治疗后杏仁核过度活动与儿童双相障碍持续存在相关。
Psychopharmacology (Berl). 2011 Aug;216(4):485-99. doi: 10.1007/s00213-011-2243-2. Epub 2011 Mar 10.
7
Do recent efficacy data on the drug treatment of acute bipolar depression support the position that drugs other than antidepressants are the treatment of choice? A conceptual review.近期关于急性双相抑郁药物治疗的疗效数据是否支持非抗抑郁药为首选治疗药物这一观点？一项概念性综述。
Eur Arch Psychiatry Clin Neurosci. 2006 Feb;256(1):1-16. doi: 10.1007/s00406-005-0591-9. Epub 2005 Aug 4.
本文引用的文献
1
Long-term lithium therapy for bipolar disorder: systematic review and meta-analysis of randomized controlled trials.双相情感障碍的长期锂盐治疗：随机对照试验的系统评价与荟萃分析
Am J Psychiatry. 2004 Feb;161(2):217-22. doi: 10.1176/appi.ajp.161.2.217.
2
What is a "mood stabilizer"? An evidence-based response.什么是“心境稳定剂”？基于证据的回答。
Am J Psychiatry. 2004 Jan;161(1):3-18. doi: 10.1176/appi.ajp.161.1.3.
3
Atypical antipsychotics attenuate neurotoxicity of beta-amyloid(25-35) by modulating Bax and Bcl-X(l/s) expression and localization.非典型抗精神病药物通过调节Bax和Bcl-X(l/s)的表达及定位来减轻β-淀粉样蛋白(25-35)的神经毒性。
J Neurosci Res. 2003 Dec 15;74(6):942-7. doi: 10.1002/jnr.10832.
4
Efficacy of olanzapine and olanzapine-fluoxetine combination in the treatment of bipolar I depression.奥氮平与奥氮平-氟西汀联合用药治疗双相I型抑郁症的疗效
Arch Gen Psychiatry. 2003 Nov;60(11):1079-88. doi: 10.1001/archpsyc.60.11.1079.
5
The antisuicidal and mortality-reducing effect of lithium prophylaxis: consequences for guidelines in clinical psychiatry.锂盐预防性治疗的抗自杀及降低死亡率作用：对临床精神病学指南的影响
Can J Psychiatry. 2003 Aug;48(7):433-9. doi: 10.1177/070674370304800702.
6
Olanzapine versus divalproex sodium for the treatment of acute mania and maintenance of remission: a 47-week study.奥氮平与丙戊酸钠治疗急性躁狂及维持缓解：一项47周的研究。
Am J Psychiatry. 2003 Jul;160(7):1263-71. doi: 10.1176/appi.ajp.160.7.1263.
7
Finding the intracellular signaling pathways affected by mood disorder treatments.找出受情绪障碍治疗影响的细胞内信号通路。
Neuron. 2003 Apr 24;38(2):157-60. doi: 10.1016/s0896-6273(03)00195-8.
8
Practice guideline for the treatment of patients with bipolar disorder (revision).双相情感障碍患者治疗实践指南（修订版）
Am J Psychiatry. 2002 Apr;159(4 Suppl):1-50.
9
Clinical outcome in a randomized 1-year trial of clozapine versus treatment as usual for patients with treatment-resistant illness and a history of mania.一项为期1年的随机试验的临床结果，该试验比较氯氮平与常规治疗对难治性疾病且有躁狂病史患者的疗效。
Am J Psychiatry. 1999 Aug;156(8):1164-9. doi: 10.1176/ajp.156.8.1164.
Zotero 插件